infertility. Female infertility
Conditions
Interventions
Intervention 1: In study group: Patients in group I (growth hormone group) receive daily injection of 4 mg growth hormone from day 21 of previous cycle until the day of hCG injection. Ovarian stimulat
Ovarian stimulation is started from second day of menstrual cycle with 300 IU of HMG monitoring by serial vaginal sonography and measurement of serum E2 levels is done. When dominant follicles reach t
Treatment - Drugs
In study group: Patients in group I (growth hormone group) receive daily injection of 4 mg growth hormone from day 21 of previous cycle until the day of hCG injection. Ovarian stimulation is started f
In control group: Patients in group II (control group)
Sponsors
Yazd research and clinical center for infertility
Eligibility
Sex/Gender
Female
Age
18 Years to 45 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: history of one or more failed in IVF cycles which three or fewer oocytes were been retrieved; serum steradiol’s level in day of HCG injection 10 and age>40 years. Exclusion criteria: Body mass index higher than 30; endocrine or metabolic disorder; endometriosis and severe male factor (azospermia ).
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Chemical pregnancy. Timepoint: 2 weeks. Method of measurement: serum BHCG. | — |
Secondary
| Measure | Time frame |
|---|---|
| Number of oocyte. Timepoint: 15 days. Method of measurement: numberring.;Number of gonadotropin ampuls. Timepoint: 15 days. Method of measurement: numberring. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMaryam Eftekhar
Yazd reaserch and clinical center for infertility
Outcome results
None listed